Arpit Rao
Impact in
-
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
-
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Prostate Cancer Treatment and Research 21
- Renal cell carcinoma treatment 10
- Prostate Cancer Diagnosis and Treatment 5
- Oncology 20
- PARP inhibition in cancer therapy 10
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Charles J. Ryan (19 shared papers)Richard C. Lauer (5 shared papers)Charles L. Wiggins (1 shared paper)Ana P. Kiess (1 shared paper)Steven P. Rowe (1 shared paper)Ximing J. Yang (1 shared paper)Martin G. Pomper (1 shared paper)Sridhar Nimmagadda (1 shared paper)
- Journals
- Journal of Clinical Oncology (20 papers)ESMO Open (2 papers)Annals of Oncology (2 papers)The Oncologist (2 papers)Therapeutic Advances in Urology (1 paper)
- Partner nations
- United StatesSpainBrazil
In The Last Decade
Arpit Rao
39 papers receiving 526 citations
Peers
Comparison fields: 5 of 62
- Pulmonary and Respiratory Medicine 291
- Oncology 159
- Cancer Research 65
- Radiology, Nuclear Medicine and Imaging 92
- Public Health, Environmental and Occupational Health 46
Countries citing papers authored by Arpit Rao
This map shows the geographic impact of Arpit Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arpit Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arpit Rao more than expected).
Fields of papers citing papers by Arpit Rao
This network shows the impact of papers produced by Arpit Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arpit Rao. The network helps show where Arpit Rao may publish in the future.
Co-authors
The 25 scholars most cited alongside Arpit Rao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prostate-specific membrane antigen as a target for cancer imaging and therapy. | 2015 | 122 |
| 2 | 2021 | 45 | |
| 3 | 2018 | 44 | |
| 4 | 2019 | 41 | |
| 5 | 2020 | 31 | |
| 6 | 2022 | 28 | |
| 7 | 2012 | 26 | |
| 8 | 1995 | 26 | |
| 9 | 2021 | 22 | |
| 10 | 2019 | 18 | |
| 11 | 2021 | 13 | |
| 12 | 2020 | 13 | |
| 13 | 2015 | 12 | |
| 14 | 2020 | 11 | |
| 15 | 2021 | 7 | |
| 16 | 2021 | 7 | |
| 17 | 2021 | 6 | |
| 18 | 2022 | 5 | |
| 19 | 2021 | 5 | |
| 20 | 2021 | 4 |
About Arpit Rao
Arpit Rao is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 42 papers that have together received 529 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (21 papers), Renal cell carcinoma treatment (10 papers), PARP inhibition in cancer therapy (10 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (291 citations), Oncology (159 citations), Cancer Research (65 citations), Radiology, Nuclear Medicine and Imaging (92 citations) and Public Health, Environmental and Occupational Health (46 citations). Arpit Rao has collaborated with scholars based in United States, Spain and Brazil. Frequent co-authors include Charles J. Ryan, Richard C. Lauer, Charles L. Wiggins, Ana P. Kiess, Steven P. Rowe, Ximing J. Yang, Martin G. Pomper, Sridhar Nimmagadda, Sangeeta Ray Banerjee and Catherine A. Foss. Their work appears in journals such as Journal of Clinical Oncology, ESMO Open, Annals of Oncology, The Oncologist and Therapeutic Advances in Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.